BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27925665)

  • 1. Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study.
    Paulson KG; Lewis CW; Redman MW; Simonson WT; Lisberg A; Ritter D; Morishima C; Hutchinson K; Mudgistratova L; Blom A; Iyer J; Moshiri AS; Tarabadkar ES; Carter JJ; Bhatia S; Kawasumi M; Galloway DA; Wener MH; Nghiem P
    Cancer; 2017 Apr; 123(8):1464-1474. PubMed ID: 27925665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy.
    Miller NJ; Church CD; Fling SP; Kulikauskas R; Ramchurren N; Shinohara MM; Kluger HM; Bhatia S; Lundgren L; Cheever MA; Topalian SL; Nghiem P
    J Immunother Cancer; 2018 Nov; 6(1):131. PubMed ID: 30482247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma.
    Samimi M; Molet L; Fleury M; Laude H; Carlotti A; Gardair C; Baudin M; Gouguet L; Maubec E; Avenel-Audran M; Esteve E; Wierzbicka-Hainaut E; Beneton N; Aubin F; Rozenberg F; Dupin N; Avril MF; Lorette G; Guyetant S; Coursaget P; Touzé A
    Br J Dermatol; 2016 Apr; 174(4):813-22. PubMed ID: 26600395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers.
    Harms KL; Zhao L; Johnson B; Wang X; Carskadon S; Palanisamy N; Rhodes DR; Mannan R; Vo JN; Choi JE; Chan MP; Fullen DR; Patel RM; Siddiqui J; Ma VT; Hrycaj S; McLean SA; Hughes TM; Bichakjian CK; Tomlins SA; Harms PW
    Clin Cancer Res; 2021 May; 27(9):2494-2504. PubMed ID: 33547200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma.
    Laude HC; Jonchère B; Maubec E; Carlotti A; Marinho E; Couturaud B; Peter M; Sastre-Garau X; Avril MF; Dupin N; Rozenberg F
    PLoS Pathog; 2010 Aug; 6(8):e1001076. PubMed ID: 20865165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus.
    Rodig SJ; Cheng J; Wardzala J; DoRosario A; Scanlon JJ; Laga AC; Martinez-Fernandez A; Barletta JA; Bellizzi AM; Sadasivam S; Holloway DT; Cooper DJ; Kupper TS; Wang LC; DeCaprio JA
    J Clin Invest; 2012 Dec; 122(12):4645-53. PubMed ID: 23114601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the IDO1/TDO2-AhR pathway in tumor cells or the tumor microenvironment is associated with Merkel cell polyomavirus status and prognosis in Merkel cell carcinoma.
    Wardhani LO; Matsushita M; Iwasaki T; Kuwamoto S; Nonaka D; Nagata K; Kato M; Kitamura Y; Hayashi K
    Hum Pathol; 2019 Feb; 84():52-61. PubMed ID: 30240768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients.
    Paulson KG; Carter JJ; Johnson LG; Cahill KW; Iyer JG; Schrama D; Becker JC; Madeleine MM; Nghiem P; Galloway DA
    Cancer Res; 2010 Nov; 70(21):8388-97. PubMed ID: 20959478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of Merkel cell polyomavirus and risk of Merkel cell carcinoma.
    Faust H; Andersson K; Ekström J; Hortlund M; Robsahm TE; Dillner J
    Int J Cancer; 2014 Feb; 134(4):844-8. PubMed ID: 23922031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Merkel Cell Carcinomas Arising in Autoimmune Disease Affected Patients Treated with Biologic Drugs, Including Anti-TNF.
    Rotondo JC; Bononi I; Puozzo A; Govoni M; Foschi V; Lanza G; Gafà R; Gaboriaud P; Touzé FA; Selvatici R; Martini F; Tognon M
    Clin Cancer Res; 2017 Jul; 23(14):3929-3934. PubMed ID: 28174236
    [No Abstract]   [Full Text] [Related]  

  • 11. Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A.
    Guadagni S; Farina AR; Cappabianca LA; Sebastiano M; Maccarone R; Zelli V; Clementi M; Chiominto A; Bruera G; Ricevuto E; Fiorentini G; Sarti D; Mackay AR
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.
    Iyer JG; Afanasiev OK; McClurkan C; Paulson K; Nagase K; Jing L; Marshak JO; Dong L; Carter J; Lai I; Farrar E; Byrd D; Galloway D; Yee C; Koelle DM; Nghiem P
    Clin Cancer Res; 2011 Nov; 17(21):6671-80. PubMed ID: 21908576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.
    Colunga A; Pulliam T; Nghiem P
    Clin Cancer Res; 2018 May; 24(9):2035-2043. PubMed ID: 29217527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and Gender Associations of Virus Positivity in Merkel Cell Carcinoma Characterized Using a Novel RNA
    Wang L; Harms PW; Palanisamy N; Carskadon S; Cao X; Siddiqui J; Patel RM; Zelenka-Wang S; Durham AB; Fullen DR; Harms KL; Su F; Shukla S; Mehra R; Chinnaiyan AM
    Clin Cancer Res; 2017 Sep; 23(18):5622-5630. PubMed ID: 28606924
    [No Abstract]   [Full Text] [Related]  

  • 15. Scientific and clinical developments in Merkel cell carcinoma: A polyomavirus-driven, often-lethal skin cancer.
    Akaike T; Nghiem P
    J Dermatol Sci; 2022 Jan; 105(1):2-10. PubMed ID: 34836718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Merkel cell polyomavirus and non-Merkel cell carcinomas: guilty or circumstantial evidence?
    Csoboz B; Rasheed K; Sveinbjørnsson B; Moens U
    APMIS; 2020 Feb; 128(2):104-120. PubMed ID: 31990105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first observation of the association of Merkel cell polyomavirus and Merkel cell carcinoma in Brazil.
    Neto CF; Oliveira WRP; Costa PVA; Cardoso MK; Barreto PG; Romano CM; Urbano PR
    Int J Dermatol; 2019 Jun; 58(6):703-706. PubMed ID: 30620056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of significant morphologic characteristics in distinguishing between Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative Merkel cell carcinomas.
    Iwasaki T; Matsushita M; Kuwamoto S; Kato M; Murakami I; Higaki-Mori H; Nakajima H; Sano S; Hayashi K
    Hum Pathol; 2013 Sep; 44(9):1912-7. PubMed ID: 23664542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyomavirus-Negative Merkel Cell Carcinoma: A More Aggressive Subtype Based on Analysis of 282 Cases Using Multimodal Tumor Virus Detection.
    Moshiri AS; Doumani R; Yelistratova L; Blom A; Lachance K; Shinohara MM; Delaney M; Chang O; McArdle S; Thomas H; Asgari MM; Huang ML; Schwartz SM; Nghiem P
    J Invest Dermatol; 2017 Apr; 137(4):819-827. PubMed ID: 27815175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.
    Lyngaa R; Pedersen NW; Schrama D; Thrue CA; Ibrani D; Met O; Thor Straten P; Nghiem P; Becker JC; Hadrup SR
    Clin Cancer Res; 2014 Apr; 20(7):1768-78. PubMed ID: 24526738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.